Search Results
Found 1 results
510(k) Data Aggregation
(288 days)
THE FREE FLOW™ DIALYSIS CATHETER IS INDICATED FOR USE IN ATTAINING LONG-TERM ACCESS FOR HEMODIALYSIS AND APHERESIS. IT MAY BE INSERTED PERCUTANEOUSLY AND PRIMARILY PLACED IN THE INTERNAL JUGULAR VEIN OF AN ADULT PATIENT. ALTERNATE INSERTION SITES INCLUDE SUBCLAVIAN VEIN AS REQUIRED. THE CURVED FREE-FLOW™ CATHETER IS INTENDED FOR INTERNAL JUGULAR VEIN INSERTION. THIS CATHETER IS INDICATED FOR A DURATION NOT TO EXCEED (12) MONTHS.
The Free Flow™ Long-Term Coaxial Catheter is manufactured by Medcomp. The catheter is polyurethane (Carbothane) that provides two dedicated (arterial/venous) access lumens. Each lumen is connected through an extension line with female luer connectors. The transition between lumen and extension is housed within & molded hub. To prevent recirculation, the venous end of the lumen is approximately 1. J" longer than the arterial. The catheter is capable of providing consistent flows up to 450 ml/min at a pressure of less than 200mm Hg. The catheter lumen is composed of a soft, thermo sensitive, Product Features: polyurethane material that is rigid upon insertion and once it reaches body temperature it becomes soft to reduce vessel trauma. The catheter assembly contains a pre-loaded stylet for ease of insertion. The catheter hub is molded from soft, pliable polyurethane to increase patient comfort. The dialysis extensions are color coded with a red luer and a clamp for the arterial lumen, a blue luer and a clamp for the venous lumen for easy identification. Physical Dimensions: The 15.5 French catheter will be available in a straight lumen design in 24, 28 and 32cm.
The provided text describes a 510(k) submission for the Free Flow™ Catheter, a hemodialysis device, and focuses on demonstrating its substantial equivalence to a predicate device through in vitro performance testing. It does not involve AI/ML, clinical studies, or human image interpretation, thus many of the requested categories are not applicable.
Here's an attempt to answer based on the provided text, indicating "Not Applicable" where the information is not present or relevant to this type of device submission:
Acceptance Criteria and Device Performance
The acceptance criteria for the Free Flow™ Catheter are implicitly derived from the performance of the legally marketed predicate device (Medcomp Ash Split-Cath® II Catheter, K040328). The study's goal was to demonstrate "substantial equivalence" to this predicate device by ensuring the Free Flow™ Catheter's in vitro performance was comparable.
Acceptance Criteria/Performance Metric | Reported Device Performance |
---|---|
Force @ Break | Met (demonstrated substantial equivalence to predicate) |
Air/Liquid Leak | Met (demonstrated substantial equivalence to predicate) |
Recirculation | Met (demonstrated substantial equivalence to predicate) |
Flow vs. Pressure | Met (demonstrated substantial equivalence to predicate) |
Cuff Shear | Met (demonstrated substantial equivalence to predicate) |
Gravity Flow | Met (demonstrated substantial equivalence to predicate) |
Flow Rate (up to) | 450 ml/min at |
Ask a specific question about this device
Page 1 of 1